Navigation Links
Drug Reduces Complications in Surgical Abortions: Study
Date:3/7/2012

WEDNESDAY, March 7 (HealthDay News) -- The drug misoprostol reduced major complications from early surgical abortion by nearly one-third, according to a new study.

Doctors often use misoprostol for cervical preparation prior to surgical abortion (vacuum aspiration). Until now, however, there were no studies large enough to determine whether the drug reduces the risk of serious complications, either immediate or delayed, according to background information in the study published in the March 8 online edition of The Lancet.

For the study, researchers from the World Health Organization (WHO) in Geneva compared rates of complications among nearly 5,000 women in nine countries who underwent surgical abortion before 12 weeks of gestation. Complications included cervical tear, uterine perforation, incomplete abortion and pelvic inflammatory disease.

Women were randomly assigned to receive either vaginal misoprostol or an inactive "placebo" three hours before the procedure.

The women in the misoprostol group were nearly one-third less likely to experience one or more complications compared to the women who received a placebo, and the risk of incomplete abortion was nearly three times higher among the women in the placebo group, the investigators found.

Women in the misoprostol group, however, were more likely to experience abdominal pain, vaginal bleeding and nausea in the three hours before surgery.

"Misoprostol reduced the overall incidence of complications, particularly incomplete abortions and unscheduled clinic visits and hospital admissions, after abortion," concluded study author Eduardo Bergel and colleagues, in a journal news release. "Providers should be aware of the side effects of the drug and inform women about these effects."

In an accompanying editorial, Dr. Allan Templeton, professor of obstetrics and gynecology at the University of Aberdeen in Scotland, wrote: "The important ongoing issue is . . . the balance between effectiveness of the procedure and the side effects of misoprostol, which will include abdominal cramps and vaginal bleeding in most women, although not to the extent of needing medical intervention before surgery."

The findings of this study suggest that "routine pharmaceutical dilation of the cervix should be recommended as an integral part of surgical abortion in all women," Templeton added.

More information

The U.S. National Library of Medicine has more about surgical abortion.

-- Robert Preidt

SOURCE: The Lancet, news release, March 7, 2012


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Service Foods Reduces its Carbon Footprint and Grows Sales
2. Health Care Reform Report Covers Uninsured, Reduces Costs
3. New cardiac CT technology drastically reduces patient radiation exposure
4. Accelerated radiation therapy reduces toxicity in patients with advanced head and neck cancers
5. Targeted delivery of losartan reduces liver inflammation and scarring
6. Drug dramatically reduces nausea and vomiting in bone marrow transplant patients
7. Soccer reduces risk of falls and bone fractures
8. Pioneering treatment reduces disability in premature babies with serious brain hemorrhage
9. New drug candidate reduces blood lipids
10. PSA Test Reduces Prostate Cancer Deaths by 40%
11. New technique reduces tobacco smoke damage to lungs in mice
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Drug Reduces Complications in Surgical Abortions: Study
(Date:2/22/2017)... , ... February 22, 2017 , ... Pet obesity in ... 54% of dogs, according to the Association for Pet Obesity Prevention (APOP). During the ... pet food issues such as the benefits of corn and grains, value of raw ...
(Date:2/22/2017)... ... February 22, 2017 , ... In today’s world, ... solutions on the market, it is easy to start feeling frustrated and confused. ... offers a complimentary security consultation. , Home Security Hardware Choices, There are innumerable ...
(Date:2/22/2017)... OAKLAND/SAN FRANCISCO BAY AREA - NORTHERN CALIFORNIA (PRWEB) , ... ... ... Forum (PMF) aims to expand the pipeline and the number of African ... support that encourages medical students and residents to pursue their careers as physicians ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... Marc Philpart, senior director at PolicyLink, will be the keynote speaker at its ... Boys and Men of Color Framework, which develops comprehensive strategies to create and ...
(Date:2/21/2017)... ... February 21, 2017 , ... Ray Insurance Agencies, a Dallas ... around Tarrant County, is embarking on a six month charity event aimed at raising ... cancer. , Cancer is one of the deadliest diseases in America; more than 7.5 ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... and HAMBURG, Germany , February 22, 2017 ... precision oncology headquartered in Hamburg, Germany and ... research institution, announced today a collaboration to support the first Indian ... research. ... Indivumed signed an agreement with an initial three-year term. The collaboration ...
(Date:2/22/2017)... 22, 2017  Soligenix, Inc. (Nasdaq: ... biopharmaceutical company focused on developing and commercializing products ... unmet medical need, announced today that its proprietary ... European patent for the treatment of psoriasis. The ... treatment of skin conditions, complements the method of ...
(Date:2/21/2017)... 21, 2017 Mass Spectrometer Market: Overview ... This report on mass spectrometer ... prospects of the market globally. The stakeholders of ... the manufacture and commercialization of various mass spectrometer ... planning to enter this market. This report comprises ...
Breaking Medicine Technology: